ClinicalTrials.Veeva

Menu

Treatment of Schizophrenic Patients With Ziprasidone (TRITON)

Viatris logo

Viatris

Status

Completed

Conditions

Schizophrenia

Treatments

Drug: Ziprasidone

Study type

Observational

Funder types

Industry

Identifiers

NCT00579670
A1281156

Details and patient eligibility

About

To determine whether ziprasidone provides good efficacy and tolerability in the treatment of schizophrenic Greek patients.

Full description

Sampling Method Details: Non-interventional study (subjects chosen by physician in accordance to their usual practice).

Enrollment

450 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Usual clinical practice of physician

Exclusion criteria

  • None

Trial contacts and locations

20

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems